Causes and Effects of Heterogeneous Perfusion in Tumors

Neoplasia

Volumn 1, Issue 3, 1999, Pages 197-207

  Gillies, Robert J ^a   Schornack, Paul A ^a   Secomb, Timothy W ^b   Raghunand, Natarajan ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Acid base balance; Angiogenesis; HIF 1; Hypoxia; Perfusion; VEEF

Indexed keywords

ACIDOSIS; ANIMAL; CELL HYPOXIA; HUMAN; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PERFUSION; PH; REVIEW; VASCULARIZATION;

ACIDOSIS; ANIMALS; CELL HYPOXIA; HUMANS; HYDROGEN-ION CONCENTRATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PERFUSION;

EID: 0033170557     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900037     Document Type: Review

References (161)

1. Gullino PM (1980). Tumor pathophysiology: the perfusion model. Antibiot Chemother 28, 35-42.
2. Jain RK (1997). The Eugene M. Landis Award Lecture 1996. Delivery of molecular and cellular medicine to solid tumors. Microcirculation 4, 1-23.
3. Vaupel P, Kallinowski F, and Okunieff P (1990). Blood flow, oxygen consumption and tissue oxygenation of human tumors. Adv Exp Med Biol 277, 895-905.
4. Kidney DD, Dietrich RB, Goyal AK, Van K, and Bradley WG, Jr. (1998). MRI of extracranial masses in children: the usefulness of gadolinium-chelate enhancement. Pediatr Radiol 28, 322-328.
5. Furman-Haran E, Grobgeld D, and Degani H (1997). Dynamic contrast-enhanced imaging and analysis at high spatial resolution of MCF7 human breast tumors. J Magn Reson 128, 161-171.
6. Tofts PS (1997). Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 7, 91-101.
7. Hawighorst H, Knapstein PG, Weikel W, Knopp MV, Zuna I, Knof A, Brix G, Schaeffer U, Wilkens C, Schoenberg SO, Essig M, Vaupel P, and van Kaick G (1997). Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res 57, 4777-4786.
8. Hawighorst H, Knopp MV, Debus J, Hoffmann U, Grandy M, Griebel J, Zuna I, Essig M, Schoenberg SO, DeVries A, Brix G, and van Kaick G (1998). Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: initial results. J Magn Reson Imaging 8, 783-788.
9. Su MY, Wang Z, Roth GM, Lao X, Samoszuk MK, and Nalcioglu O (1996). Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI. Magn Reson Med 36, 868-877.
10. Griebel J, Mayr NA, de Vries A, Knopp, MV, Gneiting T, Kremser C, Essig M, Hawighorst H, Lukas PH, and Yuh WT (1997). Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging. J Magn Reson Imaging 7, 111-119.
11. Tofts PS, and Kermode AG (1991). Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 17, 357-367.
12. Donahue KM, Weisskoff RM, and Burstein D (1997). Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imaging 7, 102-110.
13. Donahue KM, Weisskoff RM, Chesler DA, Kwong KK, Bogdanov, Jr AA, Mandeville JB, and Rosen BR (1996). Improving MR quantification of regional blood volume with intravascular T1 contrast agents: accuracy, precision, and water exchange. Magn Reson Med 36, 858-867.
14. Donahue KM, Weisskoff RM, Parmelee DJ, Callahan RJ, Wilkinson RA, Mandeville JB, and Rosen BR (1995). Dynamic Gd-DTPA enhanced MRI measurement of tissue cell volume fraction. Magn Reson Med 34, 423-432.
15. He ZQ, and Evelhoch JL (1998). Analysis of dynamic contrast enhanced MRI in tumors: relationship of derived parameters with physiologic factors. Proc Int Soc Magn Reson Med 6, 1652.
16. Reddick WE, Bhargava R, Taylor JS, Meyer WH, and Fletcher, BD (1995). Dynamic contrast-enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapy. J Magn Reson Imaging 5, 689-694.
17. Van Vierzen PB, Massuger LF, Ruys SH, and Barentsz JO (1998). Fast dynamic contrast enhanced MR imaging of cervical carcinoma. Clin Radiol 53, 183-192.
18. Barentsz JO, Berger-Hartog O, Witjes JA, Hulsbergen v, der KC, Oosterhof GO, VanderLaak JA, Kondacki H, and Ruijs SH (1998). Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging. Radiology 207, 791-797.
19. Barentsz JO, Jager GJ, Van Vierzen PB, Witjes JA, Strijk, SP, Peters H, Karssemeijer N, and Ruijs SH (1996). Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging. Radiology 201, 185-193.
20. Mayr NA, Yuh WT, Magnotta VA, Ehrhardt JC, Wheeler JA, Sorosky JI, Davis CS, Wen BC, Martin DD, Pelsang RE, Buller RE, Oberley, LW, Wellenberg DE, and Hussey DH (1996). Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay. Int J Radiat Oncol Biol Phys 36, 623-633.
21. Mayr NA, Yuh WT, Zheng J, Ehrhardt JC, Magnotta VA, Sorosky JI, Pelsang RE, Oberley LW, and Hussey DH (1998). Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging. Am J Roentgenol 170, 177-182.
22. Bonnerot V, Charpentier A, Frouin F, Kalifa C, Vanel D, and Di Paola R (1992). Factor analysis of dynamic magnetic resonance imaging in predicting the response of osteosarcoma to chemotherapy. Invest Radiol 27, 847-855.
23. Vanel D, Di Paola R, and Contesso G (1987). Magnetic resonance imaging in musculoskeletal primary malignant tumors. Magnetic Resonance Annual, pp. 237-261.
24. Acker JC, Dewhirst MW, Honore GM, Samulski TV, Tucker, JA, and Oleson JR (1990). Blood perfusion measurements in human tumours, evaluation of laser Doppler methods. Int J Hypertherm 6, 287-304.
25. Vaupel P (1998). Tumor blood flow. In Blood Perfusion And Microenvironment Of Human Tumors: Implications For Clinical Radio-Oncology. M Molls and P Vaupel, Eds. Springer-Verlag, Berlin, pp. 41-46.
26. Algire GH (1943). Transplantable tumors grown in transparent chambers in skinflaps of mice. J Natl Cancer Inst 4, 1-8.
27. Dudar TE, and Jain RK (1984). Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res 44, 605-612.
28. Dewhirst MW, Gustafson C, Gross JF, and Tso CY (1987). Temporal effects of 5.0 Gy radiation in healing subcutaneous microvasculature of a dorsal flap window chamber. Radiation Research 112, 581-591.
29. Dewhirst MW (1998). Concepts of oxygen transport at the microcirculatory level. Semin Rad Oncol 8, 143-150.
30. Dewhirst MW, Braun RD, and Lanzen JL (1998). Temporal changes in PO2 of R3230AC tumors in Fischer-344 rats. Int J Radiat Oncol Biol Phys 42, 723-726.
31. Kimura H, Braun RD, Ong ET, Hsu R, Secomb TW, Papahadjopoulos D, Hong, and Dewhirst MW (1996). Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res 56, 5522-5528.
32. Blancher C, and Harris AL (1998). The molecular basis of the hypoxia response pathway: tumour hypoxia as a therapy target. Cancer Metastasis Rev 17, 187-194.
33. Biaglow JE, Manevich Y, Leeper D, Chance B, Dewhirst MW, Jenkins WT, Tuttle SW, Wroblewski K, Glickson JD, Stevens C, and Evans SM (1998). MIBG inhibits respiration: potential for radio-and hyperthermic sensitization. Int J Radiat Oncol Biol Phys 42, 871-876.
34. Dewhirst MW, Ozimek EJ, Gross J, and Cetas TC (1980). Will hyperthermia conquer the elusive hypoxic cell? Implications of heat effects on tumor and normal-tissue microcirculation. Radiology 137, 811-817.
35. Nozue M, Lee I, Yuan F, Teicher BA, Brizel DM, Dewhirst, MW, Milross CG, Milas L, Song CW, Thomas CD, Guichard M, Evans SM, Koch CJ, Lord EM, Jain RK, and Suit HD (1997). Interlaboratory variation in oxygen tension measurement by Eppendorf "Histograph" and comparison with hypoxic marker. J Surg Oncol 66, 30-38.
36. Halpern HJ, Yu C, Peric M, Barth ED, Karczmar GS, River, JN, Grdina DJ, and Teicher BA (1996). Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetry. Radiat Res 145, 610-618.
37. Hasegawa Y, Formato JE, Latour LL, Gutierrez JA, Liu KF, Garcia JH, Sotak CH, and Fisher M (1996). Severe transient hypoglycemia causes reversible change in the apparent diffusion coefficient of water. Stroke 27, 1648-1655.
38. Mason RP, Hunjan S, Le D, Constantinescu A, Barker BR, Wong PS, Peschke P, Hahn EW, and Antich PP (1998). Regional tumor oxygen tension: fluorine echo planar imaging of hexafluorobenzene reveals heterogeneity of dynamics. Int J Radiat Oncol Biol Phys 42, 747-750.
39. Mason RP, Rodbumrung W, and Antich PP (1996). Hexafluorobenzene: a sensitive 19F NMR indicator of tumor oxygenation. NMR Biomed 9, 125-134.
40. Al-Hallaq HA, River JN, Zamora M, Oikawa H, and Karczmar GS (1998). Correlation of magnetic resonance and oxygen microelectrode measurements of carbogen-induced changes in tumor oxygenation. Int J Radiat Oncol Biol Phys 41, 151-159.
41. Oikawa H, Al-Hallaq HA, Lewis MZ, River JN, Kovar DA, and Karczmar GS (1997). Spectroscopic imaging of the water resonance with short repetition time to study tumor response to hyperoxia. Magn Reson Med 38, 27-32.
42. Wiebe LI, and Stypinski D (1996). Pharmacokinetics of SPECT radiopharmaceuticals for imaging hypoxic tissues. Q J Nucl Med 40, 270-284.
43. Koh WJ, Rasey JS, Evans ML, Grierson JR, Lewellen TK, Graham MM, Krohn, KA, and Griffin TW (1992). Imaging of hypoxia in human tumors with (F-18)fluoromisonidazole. Int J Radiat Oncol Biol Phys 22, 199-212.
44. Kavanagh MC, Sun A, Hu Q, and Hill RP (1996). Comparing techniques of measuring tumor hypoxia in different murine tumors: Eppendorf pO2 Histograph, (3H)misonidazole binding and paired survival assay. Radiat Res 145, 491-500.
45. Rasey JS, Koh WJ, Evans ML, Peterson LM, Lewellen TK, Graham MM, and Krohn KA (1996). Quantifying regional hypoxia in human tumors with positron emission tomography of (18F)fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys 36, 417-428.
46. Wouters BG, and Brown JM (1997). Cells at intermediate oxygen levels can be more important that the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. Radiat Res 147, 541-550.
47. Warburg O (1956). On the origin of cancer cells. Science 123, 309-314.
48. Wike-Hooley JL, Haveman J, and Reinhold HS (1984). The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol 2, 343-366.
49. 31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate. Am J Physiol 267, C195-C203.
50. McCoy CL, Parkins CS, Chaplin DJ, Griffiths JR, Rodrigues LM, and Stubbs M (1995). The effect of blood flow modification on ontra-and extracellular pH measured by 31P magnetic resonance spectroscopy in murine tumours. Br J Cancer 72, 905-911.
51. 2) breathing. Proc Int Soc Magn Reson Med 3, 1093.
52. Gullino PM (1976). In vivo utilization of oxygen and glucose by neoplastic tissue. Adv Exp Med Biol 75, 521-536.
53. Gullino PM, Grantham FH, and Courtney AH (1967). Glucose consumption by transplanted tumors in vivo. Cancer Res 27, 1031-1040.
54. Gullino PM, Grantham FH, and Courtney AH (1967). Utilization of oxygen by transplanted tumors in vivo. Cancer Res 27, 1020-1030.
55. Gullino PM, Grantham FH, Courtney AH, and Losonczy I (1967). Relationship between oxygen and glucose consumption by transplanted tumors in vivo. Cancer Res 27, 1041-1052.
56. Freyer JP, and Sutherland RM (1986). Proliferative and clonogenic heterogeneity of cells from EMT6/Ro multicellular spheroids induced by the glucose and oxygen supply. Cancer Res 46, 3513-3520.
57. ThomLinson RH, and Gray LH (1955). The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9, 539-549.
58. Krogh A (1919). The rate of diffusion of gases through animal tissues, with some remarks on the coefficient of invasion. J Physiol 52, 391-408.
59. Krogh A (1919). The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue. J Physiol 52, 409-415.
60. Freyer JP, and Sutherland RM (1985). A reduction in the in situ of oxygen and glucose consumption of cells in EMT6/RO spheroids during growth. J Cell Physiol 125, 516-524.
61. Freyer JP, and Sutherland RM (1983). Determination of diffusion constants for metabolites in multicell tumor spheroids. Oxygen Transport to Tissue IV. Adv. Exp. Med. Biol. 159, 43-47
62. Neeman M, Jarrett KA, Sillerud LO, and Freyer JP (1991). Self-diffusion of water in multicellular spheroids measured by magnetic resonance microimaging. Cancer Res 51, 4072-4079.
63. Sillerud LO, Freyer JP, Neeman M, and Mattingly MA (1990). Proton NMR microscopy of multicellular tumor spheroid morphology. Magn Reson Med 16, 380-389.
64. 2 Gradients in Solid Tumors in vivo: High-Resolution Measurements Reveal a Lack of Correlation. Nature Med 3, 177-182.
65. Hall EJ (1994). Radiobiology for the Radiologist. J.B. Lippincott, Philadelphia.
66. Parliament MB, Chapman JD, Urtasun RC, McEwan AJ, Golberg L, Mercer JR, Mannan RH, and Wiebe LI (1992). Non-invasive assessment of human tumour hypoxia with 1231-iodoazomycin arabinoside: preliminary report of a clinical study. Br J Cancer 65, 90-95.
67. Michael B, Adams G, Hewitt H, Jones W, and Watts M (1973). A posteffect of oxygen in irradiated bacteria: A submillisecond fast mixing study. Radiat Res 54, 239-251.
68. Freitas I (1985). Role of hypoxia in photodynamic therapy of tumors. Tumori 71, 251-259.
69. Yuan J, Mahama-Relue PA, Fournier RL, and Hampton JA (1997). Predictions of mathematical models of tissue oxygenation and generation of singlet oxygen during photodynamic therapy. Radiat Res 148, 386-394.
70. Griffiths JR (1991). Are cancer cells acidic? Br J Cancer 64, 425-427.
71. Gillies RJ, and Deamer DW (1978). Intracellular pH: Methods and applications. Curr Top Bioenergetics 9, 63-87.
72. Roos A (1978). Weak acids, weak bases and intracellular pH. Respir Physiol 33, 27-30.
73. Raghunand R, Martinez-Zaguilan R, Wright SH, and Gillies RJ (1999). pH and Drug Resistance II. Turnover of acidic vesicles and resistance to weakly basic chemotherapeutic drugs. Biochem Pharmacol 57, 1047-1058.
74. Tannock IF, and Rotin D (1989). Acid pH in Tumors and Its Potential for Therapeutic Exploitation. Cancer Res 49, 4373-4384.
75. Roepe PD, Wei LY, Cruz J, and Carlson D (1993). Lower electrical membrane potential and altered pHi homeostasis in multidrug-resistant (MDR) cells: further characterization of a series of MDR cell lines expressing different levels of p-glycoprotein. Biochemistry 32, 11042-11056.
76. Simon S, Roy D, and Schindler M (1994). Intracellular pH and the control of multidrug resistance. Cell Biol 91, 1128-1132.
77. Gerweck L, and Seetharaman K (1996). Cellular pH gradient in tumor versus normal tissue: Potential for exploitation for the treatment of cancer. Cancer Res 56, 1194-1198.
78. Raghunand N, He X, van Sluis R, Mahoney B, Baggett B, Taylor CW, Paine-Murrieta G, Roe D, Bhujwalla ZM, and Gillies RJ (1999). Enhancement of chemotherapy by manipulation of tumor pH. Br J Cancer 80, 1011.
79. Taylor CW, Dalton WS, Parrish PR, Gleason MC, Bellamy WT, Thompson FH, Roe DJ, and Trent JM (1991). Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. Br J Cancer 63, 923-929.
80. Simon SM, and Schindler M (1994). Cell biological mechanisms of multidrug resistance in tumors. Proc Nat Acad Sci USA 91, 3497-3504.
81. LeBoeuf RA, and Kerckaert GA (1987). Enhanced morphological transformation of early passage syrian hamster embryo cells cultured in medium with a reduced bicarbonate concentration and pH. Carcinogenesis 8, 689-697.
82. LeBoeuf RA, Kerckaert GA, Aardema MJ, Poiley JA, and Raineri R (1990). Enhanced morphological and neoplastic transformation of syrian hamster embryo cells cultured at pH 6.70. Mutat Environment D, 219-228.
83. LeBoeuf RA, Kerckaert GA, Poiley JA, and Raineri R (1989). An interlaboratory comparison of enhanced morphological transformation of syrian hamster embryo cells cultured under conditions of reduced bicarbonate concentration and pH. Mutat Res 222, 205-218.
84. Morita T, Nagaki T, Fukuda I, and Okumura K (1992). Clastogenicity of low pH to various cultured mammalian cells. Mutat Res 268, 297-305.
85. Morita T, Takeda K, and Okumura K (1990). Evaluation of clastogenicity of formic acid, acetic acid, and lactic acid on cultured mammalian cells. Mutat Res 240, 195-202.
86. Reynolds TY, Rockwell S, and Glazer PM (1996). Genetic instability induced by the tumor microenvironment. Cancer Res 56, 5754-5757.
87. Martinez-Zaguilan R, Seftor EA, Seftor REB, Chu YW, Gillies RJ, and Hendrix MJC (1996). Acidic pH Enhances The Invasive Behavior of Human Melanoma Cells. Clin. Exp Metastasis 14, 176-186.
88. Schlappack OK, Zimmermann A, and Hill RP (1991). Glucose starvation and acidosis: effect on experimental metastasic potential, DNA content and MTX resistance of murine tumour cells. Br J Cancer 64, 663-670.
89. Montcourrier P, Silver I, Farnoud R, Bird I, and Rochefort H (1997). Breast Cancer Cells Have a High Capacity To Acidify Extracellular Milieu by a Dual Mechanism. Clin Exp Metastasis 15, 382-392.
90. Rozhin J, Sameni M, Ziegler G, and Sloane BF (1994). Pericellular pH affects distribution and secretion of cathepsin B in Malignant Cells. Cancer Res 54, 6517-6525.
91. Cuvier C, Jang A, and Hill RP (1997). Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion. Clin Exp Metastasis 15, 19-25.
92. Jang A, and Hill RP (1997). An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells. Clin Exp Metastasis 15, 469-483.
93. Graham CH, Forsdike J, Fitzgerald CJ, and Macdonald-Goodfellow S (1999). Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer 80, 617-623.
94. Fitzpatrick TE, and Graham CH (1998). Stimulation of plasminogen activator inhibitor-1 expression in immortalized human trophoblast cells cultured under low levels of oxygen. Exp CellRes 245, 155-162.
95. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR, and Dewhirst MW (1996). Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56, 941-943.
96. Sundfor K, Lyng H, and Rofstad EK (1998). Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br J Cancer 78, 822-827.
97. Kim CY, Tsai MH, Osmanian C, Graeber TG, Lee JE, Giffard RG, DiPaolo JA, Peehl DM, and Giaccia AJ (1997). Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions. Cancer Res 57, 4200-4204.
98. Neeman M, Abramovitch R, Schiffenbauer YS, and Tempel C (1997). Regulation of angiogenesis by hypoxic stress: from solid tumours to the ovarian follicle. Int J Exp Pathol 78, 57-70.
99. Gullino PM (1983). Angiogenesis and neoplastic growth. Prog Clin Biol Res 132C, 101-107.
100. Gullino PM (1978). Angiogenesis and oncogenesis. J Natl Cancer Inst 61, 639-643.
101. Hanahan D, and Folkman J (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
102. Knighton DR, Hunt TK, Scheuenstuhl H, Halliday BJ, Werb, and Banda MJ (1983). Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 221, 1283-1285.
103. Scott PA, Gleadle JM, Bicknell R, and Harris AL (1998). Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. Int J Cancer 75, 706-712.
104. Shweiki D, Itin A, Soffer D, and Keshet E (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845.
105. Shweiki D, Neeman M, Itin A, and Keshet E (1995). Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Nat Acad Sci USA 92, 768-772.
106. Potgens AJ, Lubsen NH, van Altena MC, Schoenmakers JG, Ruiter DJ, and de Waal RM (1995). Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice. Am J Pathol 146, 197-209.
107. Olson TA, Mohanraj D, Roy S, and Ramakrishnan S (1997). Targeting the tumor vasculature: inhibition of tumor growth by a vascular endothelial growth factor-toxin conjugate. Int J Cancer 73, 865-870.
108. Benjamin LE, and Keshet E (1996). Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Nat Acad Sci USA 94, 8761-8766.
109. Benjamin LE, Golijanin D, Itin A, Pode D, and Keshet E (1999). Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103, 159-165.
110. Yu C, Harris SR, and Thorgeirsson UP (1997). Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells. Cancer Res 57, 3924-3928.
111. Stein I, Neeman M, Shweiki D, Itin A, and Keshet E (1995). Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 15, 5363-5368.
112. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, and Keshet E (1998). Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485-490.
113. Brooks SE, Gu X, Kaufmann PM, Marcus DM, and Caldwell RB (1998). Modulation of VEGF production by pH and glucose in retinal Muller cells. Curr Eye Res 17, 875-882.
114. Griffiths L, Dachs GU, Bicknell R, Harris AL, and Stratford IJ (1997). The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res 57, 570-572.
115. Phillips PG, Bimby LM, and Narendran A (1995). Hypoxia induces capillary network formation in cultured bovine pulmonary microvessel endothelial cells. Am J Physiol 268, L789-L800.
116. Kuwabara K, Ogawa S, Matsumoto M, Koga S, Clauss M, Pinsky DJ, Lyn P, Leavy J, Witte L, and Joseph-Silverstein J (1995). Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Nat Acad Sci USA 92, 4606-4610.
117. Kumar R, Kuniyasu H, Bucana CD, Wilson MR, and Fidler IJ (1998). Spatial and temporal expression of angiogenic molecules during tumor growth and progression. Oncol Res 10, 301-311.
118. Davis S, and Yancopoulos GD (1999). The angiopoietins: Yin and Yang in angiogenesis. Curr Top Microbiol Immunol 237, 173-185.
119. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, and Yancopoulos GD (1996). Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87, 1161-1169.
120. Mandriota SJ, and Pepper MS (1998). Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 83, 852-859.
121. Poiseuille J (1846). Recherches expérimentales sur le mouvement des liquides dans les tubes de très petits diamètres. Mém Savant Étrangers Paris 9, 433-544.
122. Pries AR, Secomb T, Gessner T, Sperandio MB, Gross J, and Gaehtgens P (1994). Resistance to blood flow in microvessels in vivo. Circ Res 75, 904-915.
123. Less JR, Posner MC, Skalak TC, Wolmark N, and Jain RK (1997). Geometric resistance and microvascular network architecture of human colorectal carcinoma. Microcirculation 4, 25-33.
124. Wu NZ, Da D, Rudoll TL, Needham D, Whorton AR, and Dewhirst, MW (1993). Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue. Cancer Res 53, 3765-3770.
125. Jain RK (1996). 1995 Whitaker Lecture: delivery of molecules, particles, and cells to solid tumors. Ann Biomed Eng 24, 457-473.
126. Dewhirst MW, Tso CY, Oliver R, Gustafson CS, Secomb TW, and Gross JF (1989). Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. Int J Radiat Oncol Biol Phys 17, 91-99.
127. Brizel DM, Klitzman B, Cook JM, Edwards J, Rosner G, and Dewhirst MW (1993). A comparison of tumor and normal tissue microvascular hematocrits and red cell fluxes in a rat window chamber model. Int J Radiat Oncol Biol Phys 25, 269-276.
128. Foltz RM, McLendon RE, Friedman HS, Dodge RK, Bigner DD, and Dewhirst MW (1995). A pial window model for the intracranial study of human glioma microvascular function. Neurosurgery 36, 976-984.
129. Bevilacqua P, Barbareschi M, Verderio P, Boracchi P, Caffo O, Dalla, Palma P, Meli S, Weidner N, and Gasparini G (1995). Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma-results of a multi-parametric study. Breast Cancer Res Treat 36, 205-217.
130. Weidner N (1995). Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 36, 169-180.
131. Weidner N (1995). Intratumor microvessel density as a prognostic factor in cancer. Am J Path 147, 9-19.
132. Ziche M, and Gullino PM (1982). Angiogenesis and neoplastic progression in vitro. J Natl Cancer Inst 69, 483-487.
133. Brem SS, Jensen HM, and Gullino PM (1978). Angiogenesis as a marker of preneoplastic lesions of the human breast. Cancer 41, 239-244.
134. Weidner N, and Folkman J (1996). Tumoral vascularity as a prognostic factor in cancer. Important Adv Oncol 167-190.
135. Teicher BA (1995). Angiogenesis and cancer metastases: therapeutic approaches. Crit Rev Oncol Hematol 20, 9-39.
136. Secomb TW, Hsu R, Ong ET, Gross JF, and Dewhirst MW (1995). Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors. Acta Oncol 34, 313-316.
137. Secomb TW, Hsu R, Braun RD, Ross JR, Gross JF, and Dewhirst, MW (1998). Theoretical simulation of oxygen transport to tumors by three-dimensional networks of microvessels. Adv Exp Med Biol 454, 629-634.
138. Abramovitch R, Meir G, and Neeman M (1995). Neovascularization induced growth of implanted C6 glioma multicellular spheroids: magnetic resonance microimaging. Cancer Res 55, 1956-1962.
139. 2 gradients in window chamber tumours: impact on tumour hypoxia. Br J Cancer 79, 1717-1722.
140. Pries AR, Secomb T, and Gaehtgens P (1998). Structural adaptation and stability of microvascular networks: theory and simulations. Am J Physiol 275, H349-H360.
141. Gulledge CJ, and Dewhirst MW (1996). Tumor oxygenation: a matter of supply and demand. Anticancer Res 16, 741-749.
142. Scott PA, Gleadle JM, Bicknell R, and Harris AL (1998). Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. Int J Cancer 75, 706-712.
143. Berg BR, and Sarelius IH (1996). Erythrocyte flux in capillary networks during maturation: implications for oxygen delivery. Am J Physiol 271, H2263-H2273.
144. Sweeney TE, and Sarelius IH (1989). Arteriolar control of capillary cell flow in striated muscle. Circ Res 64, 112-120.
145. Duling BR, Kuschinsky W, and Wahl M (1979). Measurements of the perivascular PO2 in the vicinity of the pial vessels of the cat. Pflugers Arch 383, 29-34
146. Torres FI, Kerger H, and Intaglietta M (1996). pO2 measurements in arteriolar networks. Microvasc Res 51, 202-212.
147. Berg BR, and Sarelius IH (1995). Functional capillary organization in striated muscle. Am J Physiol 268, H1215-H1222.
148. Kiani MF, Cokelet GR, and Sarelius IH (1993). Effect of diameter variability along a microvessel segment on pressure drop. Microvasc Res 45, 219-232.
149. Kiani MF, Pries AR, Hsu LL, Sarelius IH, and Cokelet GR (1994). Fluctuations in microvascular blood flow parameters caused by hemodynamic mechanisms. Am J Physiol 266, H1822-H1828.
150. Adair TH, Gay WJ, and Montani JP (1990). Growth regulation of the vascular system: evidence for a metabolic hypothesis. Am J Physiol 259, R393-R404.
151. Rubin P, and Casarett G (1966). Microcirculation of Tumors Part 1: anatomy, function and Necrosis. Clin Radiol 17, 220-229.
152. Hori K, Suzuki M, Tanda S, and Saito S (1999). In vivo analysis of tumor vascularization in the rat. Jpn J Cancer Res 81, 279-288.
153. Herbst RS, Takeuchi H, and Teicher BA (1998). Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma models. Cancer Chemother Pharmacol 41, 497-504.
154. Teicher BA, Ara G, Buxton D, Leonard J, and Schaub RG (1998). Optimal scheduling of interleukin-12 and fractionated radiation therapy in the murine Lewis lung carcinoma. Radiat Oncol Invest 6, 71-80.
155. Kakeji Y, and Teicher BA (1997). Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents. Invest New Drugs 15, 39-48.
156. Teicher BA, Dupuis NP, Robinson MF, Emi Y, and Goff DA (1995). Antiangiogenic treatment (TNP-470/minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma. Oncol Res 7, 237-243.
157. Mauceri HJ, Hanna NN, Beckett MA, Gorski DH, Staba MJ, Stellato KA, Bigelow K, Heimann R, Gately S, Dhanabal M, Soff GA, Sukhatme VP, Kufe, DW, and Weichselbaum RR (1998). Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature 394, 287-291.
158. Hawighorst H, Knapstein PG, Knopp MV, Weikel W, Brix G, Zuna I, Schonberg SO, Essig M, Vaupel P, and van Kaick G (1998). Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. Cancer Res 58, 3598-3602.
159. Abramovitch R, Frenkiel D, and Neeman M (1998). Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging. Magn Reson Med 39, 813-824.
160. Griffiths JR, Taylor NJ, Howe FA, Saunders MI, Robinson SP, Hoskin PJ, Powell ME, Thoumine M, Caine LA, and Baddeley H (1997). The response of human tumors to carbogen breathing, monitored by Gradient-Recalled Echo Magnetic Resonance Imaging. Int J Radiat Oncol Biol Phys 39, 697-701.
161. Vaupel P (1992). Physiological properties of malignant tumours. NMR Biomed 5, 220-225.